VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+10.35%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-1.9%)
Cap. Flow
-$8.35M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
62
Reduced
100
Closed
19
Top Buys
| 1 |
Fidelity MSCI Financials Index ETF
FNCL
|
$1.41M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.15M |
| 3 |
Verastem
VSTM
|
$985K |
| 4 |
Arrowhead Research
ARWR
|
$933K |
| 5 |
Cartesian Therapeutics
RNAC
|
$884K |
Top Sells
Sector Composition
| 1 | Healthcare | 77.9% |
| 2 | Financials | 0.8% |
| 3 | Technology | 0.58% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Energy | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Nektar Therapeutics
NKTR
$543M
| $632K | 0.56% |
12,942
-2,069
| -14% | -$101K |
|
|
SYRS
127
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $630K | 0.56% |
+61,719
| New | +$630K |
|
|
ACGN
128
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $626K | 0.55% |
474,609
+89,762
| +23% | +$118K |
|
129
Rigel Pharmaceuticals
RIGL
$710M
| $617K | 0.55% |
217,985
+5,103
| +2% | +$14.5K |
|
|
MLNT
130
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $615K | 0.54% |
96,866
+47,838
| +98% | +$304K |
|
131
Arcus Biosciences
RCUS
$1.24B
| $609K | 0.54% |
+49,734
| New | +$609K |
|
132
Fidelity MSCI Information Technology Index ETF
FTEC
$15.1B
| $608K | 0.54% |
11,009
-50,996
| -82% | -$2.82M |
|
133
Direxion Daily Technology Bull 3x Shares
TECL
$3.42B
| $586K | 0.52% |
+4,399
| New | +$586K |
|
134
Alaunos Therapeutics
TCRT
$4.43M
| $574K | 0.51% |
190,062
+12,663
| +7% | +$38.1K |
|
|
KERX
135
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $544K | 0.48% |
144,564
-54,525
| -27% | -$205K |
|
|
SIOX
136
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $486K | 0.43% |
214,907
+76,539
| +55% | +$173K |
|
137
Gyre Therapeutics
GYRE
$734M
| $362K | 0.32% |
+31,061
| New | +$362K |
|
138
Itaú Unibanco
ITUB
$74.8B
| $241K | 0.21% |
23,236
+12,296
| +112% | +$128K |
|
139
Alibaba
BABA
$325B
| $194K | 0.17% |
1,045
-108
| -9% | -$20.1K |
|
140
Petrobras Class A
PBR.A
$73.4B
| $161K | 0.14% |
18,269
+11,170
| +157% | +$98.4K |
|
141
HDFC Bank
HDB
$181B
| $149K | 0.13% |
1,417
-130
| -8% | -$13.7K |
|
142
Ambev
ABEV
$33.5B
| $147K | 0.13% |
31,782
+16,298
| +105% | +$75.4K |
|
143
America Movil
AMX
$58.9B
| $105K | 0.09% |
6,308
-1,533
| -20% | -$25.5K |
|
144
Sociedad Química y Minera de Chile
SQM
$12.5B
| $84K | 0.07% |
1,743
-358
| -17% | -$17.3K |
|
145
Fomento Económico Mexicano
FMX
$29B
| $78K | 0.07% |
883
-250
| -22% | -$22.1K |
|
146
Adobe
ADBE
$148B
| $66K | 0.06% |
271
| – | – |
|
147
Cisco
CSCO
$268B
| $63K | 0.06% |
1,456
| – | – |
|
148
JD.com
JD
$44.2B
| $61K | 0.05% |
1,566
-14
| -0.9% | -$545 |
|
149
Visa
V
$681B
| $57K | 0.05% |
428
| – | – |
|
150
Johnson & Johnson
JNJ
$429B
| $49K | 0.04% |
406
| – | – |
|